Showing 1,541 - 1,560 results of 228,301 for search '(( 5 ((fold decrease) OR (mean decrease)) ) OR ( 10 ((ng decrease) OR (a decrease)) ))', query time: 1.77s Refine Results
  1. 1541
  2. 1542
  3. 1543
  4. 1544

    V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

    Published 2015
    “…Data are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116501#pone.0116501.t005" target="_blank">Table 5</a>. …”
  5. 1545

    Changes in neural activity were decreased in animals pre-exposed to 5-HT and <i>mod-1</i> mutants when the worms switched their locomotive direction. by Haruka Mori (8082215)

    Published 2019
    “…<p>(A–F) the neural activity of the RID changes during the transition periods from backward to forward locomotion (A–C) and from forward to backward locomotion (D–F) in the mock (A: p = 1.5 × 10<sup>−5</sup>; D: p = 5.5 × 10<sup>−13</sup>), 5-HT exposed (B: p = 0.092; E: p = 0.79), and <i>mod-1</i> mutant (C: p = 0.081; F: p = 0.93) groups. …”
  6. 1546
  7. 1547
  8. 1548
  9. 1549
  10. 1550

    Increase of proliferating progenitor cells and decrease of terminally differentiated granule neurons in the immature dentate gyrus of <i>PC3/Tis21</i>-null mice at P14. by Stefano Farioli-Vecchioli (256006)

    Published 2009
    “…<p>(<b>A</b>) The whole population of progenitor cells entering in S-phase, labeled by a short pulse of BrdU (1hour) and by the progenitor cell marker Sox2 (BrdU/Sox2-positive), increased significantly in <i>PC3/Tis21</i>-null mice (1.6-fold). (<b>B</b>, <b>C</b>) The same significant increase is observed for the number of dividing progenitor cells, identified either as (<b>B</b>) Ki67-positive, or as (<b>C</b>) Ki67/Sox2-positive cells (1.5-fold). …”
  11. 1551
  12. 1552
  13. 1553
  14. 1554
  15. 1555
  16. 1556
  17. 1557
  18. 1558
  19. 1559
  20. 1560

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”